Biotech

All Articles

Boundless Biography makes 'small' layoffs 5 months after $100M IPO

.Simply five months after protecting a $100 million IPO, Boundless Biography is actually actually gi...

Halda's $126M will advance 'hold and kill' lump medicines

.The first stages of oncology R&ampD aren't short of intriguing brand new methods, and also Halda Th...

Lykos 'regrets' certainly not making known study offenses along with publisher

.Psychopharmacology has drawn three short articles concerning midstage professional test records exa...

Analysts examine Avidity's DMD succeed, revealing subtleties in records

.Avidity Biosciences pleased entrepreneurs along with period 1/2 records in Duchenne muscular dystro...

Actinogen's cortisol blocker neglects stage 2 clinical depression research

.Actinogen Medical's cortisol blocker has missed out on the primary endpoint of a stage 2 study in d...

Bivictrix chooses going private only means to take ADC into clinic

.Antibody-drug conjugates (ADCs) have actually been at the center of lots of a billion-dollar biobuc...

TPG tops up funds to $580M for assets around life sciences

.Resource supervisor TPG, which has sustained biotechs such as Sionna Therapies and Santa Ana Bio, h...

Merck quits phase 3 TIGIT test in bronchi cancer cells for futility

.Merck &amp Co.'s TIGIT system has experienced an additional problem. Months after shuttering a stag...

After a challenging year, Exscientia folds in to Recursion

.After a year defined through pipeline hairstyles, the departure of its CEO and unemployments, Exsci...

Cullinan, after $25M offer, return bispecific to Port

.Cullinan Therapeutics was actually wowed sufficient with Port BioMed's bispecific immune system act...